baber/WOPTO huggingface dataset:
Patent JP-3657983-B2 (JP)
IPC: H04B10/2513
Filed: 1995-04-20
Granted: 2005-06-08
Abstract: PCT No. PCT/FR95/00510 Sec. 371 Date Dec. 13, 1995 Sec. 102(e) Date Dec. 13, 1995 PCT Filed Apr. 20, 1995 PCT Pub. No. WO95/29539 PCT Pub. Date Nov. 2, 1995An optical transmission method and device consisting of coding a binary data pattern (SI) to be transmitted in the form of a second binary signal (SM), by differential coding; filtering the second binary signal (SM) to obtain a duobinary signal (SMF having three meaningful values (-1, 0+/- epsilon , +a) and a narrower bandwidth; and modulating an optical carrier according to the values assumed by the filtered signal (SMF), the modulated carrier having a maximal amplitude to represent the maximal value (+a) and the minimal value (+a) of the duobinary signal (SMF), the phase of the modulated carrier being shifted by  theta 1 and  theta 2= theta 1+180 DEG , respectively, and a minimal amplitude to represent values (0+/- epsilon ) near 0 if the duobinary signal. The method of this invention is suitable for long distance fiber-optic transmissions.
Patent JP-3046358-B2 (JP)
IPC: C04B28/04
Filed: 1997-02-13
Granted: 2000-05-29
Abstract: Semi-finished constructional element for panelling surfaces, comprising a sheet of glass with a layer of composite mortar (I) on one side, consisting of (a) a finely divided neutral aggregate and (b) cement mixed with an aqueous dispersion of (c) a polyacrylic acid derivative. Component (c) has a logarithmic decrement (determined as described in DIN 53445) with a maximum at a temperature below 0 degrees C, and the mortar is hardened on the glass with a deficiency of hydration water.
Patent JP-3105003-B2 (JP)
IPC: B32B7/02
Filed: 1997-05-08
Granted: 2000-10-30
Abstract: A multiple ply tissue paper structure is disclosed. The paper structure includes a ply comprising discrete relatively low density regions dispersed throughout a relatively high density continuous network. The paper structure also include a ply which does not include discrete relatively low density regions dispersed throughout a relatively high density continuous network. The different structures of the two plies provide improved absorbency over a homogeneous multiple ply structure.
Patent JP-4108142-B2 (JP)
IPC: F17C1/00
Filed: 1999-04-28
Granted: 2008-06-25
Abstract: A fluid storage and dispensing system (10) comprising a vessel (12) for holding a fluid (17) at a desired pressure. The vessel has a pressure regulator (26) set at a predetermined pressure. The regulator may be interiorly or exteriorly positioned, single-staged or multi-staged, and is associated with a port of the vessel. A dispensing assembly, e.g. including a flow control means such as a valve (20), is arranged in gas/vapor flow communication with the regulator (26), whereby the opening of the valve effects dispensing of gas/vapor from the vessel (12). The fluid in the vessel may be constituted by a liquid that is confined in the vessel at a pressure in excess of its liquefaction pressure at prevailing temperature conditions, e.g. ambient (room) temperature.
Patent ES-2190841-B2 (ES)
Title: Envase para bebidas refrescantes y similares con pajita flexible interior incorporada.
Inventor: SALVADO FERNANDEZ JUAN
IPC: B65D77/28
Filed: 2000-04-12
Granted: 2004-08-01
Abstract: Envase para bebidas refrescantes y similares con pajita flexible interior incorporada. Comprende un cuerpo (1) destinado a contener una bebida refrescante o similar y una pajita flexible (5) el cual incluye una tapa (4) provista de medios de apertura formados por una anilla (6) unida de manera giratoria a un elemento laminar (7) mediante una zona de debilitamiento (10) el cual queda unido a una zona de desprendimiento (8) de la tapa (4) donde se une inferiormente un elemento de sujeción (11) de la pajita (5) de manera que la apertura de la tapa (4) provoca la proyección de la pajita (5) hacia el exterior. La pajita (5) incorpora un tubo elástico (19) dotado de protuberancias radiales (20) que quedan en contacto con la pared interior (21) de la pajita (5) para impedir la circulación de aire en el espacio (22) entre la pajita (5) y el tubo (19).
Patent ES-2229915-B2 (ES)
Title: Parche para la toma de muestras de fluido corporal.
Inventor: ELIZALDE BORRAS CARLOS
IPC: G01N1/10
Filed: 2003-07-14
Granted: 2005-11-16
Abstract: Parche para la toma de muestras de fluido corporal. El parche está constituido por la superposición de varias láminas, una primera de protección (1) con la cara interna encerada o con un tratamiento equivalente, una lámina absorbente (2) de menor anchura y longitud centrada que se encuentra sujeta por la capa superior de polietileno (3) por su superficie inferior adherente y sobre estas capas, opcionalmente, una cuarta capa anular (4) que apoya y queda adherida sobre el borde de polietileno (3) para su protección; donde, la capa absorbente (2) presenta dos entalladuras (2.1) centradas en los lados mayores y conectadas por una línea (2.2) de debilitamiento, además de mostrarse en cada una de las partes que separa esta línea (2.2) de debilitamiento un número (2.3) de identificación más un guarismo, preferiblemente una letra, que distingue una y otra parte.
Patent ES-2556156-B2 (ES)
Title: Material polimérico para la especiación de mercurio inorgánico y metilmercurio
Inventor: MUNOZ OLIVAS MARÍA RIANSARES
IPC: G01N33/20
Filed: 2014-07-07
Granted: 2016-04-26
Abstract: Material polimérico para la especiación de mercurio inorgánico y metilmercurio.#El mercurio es un elemento pesado de elevada toxicidad debido principalmente a su elevada biodisponibilidad y bioacumulación en el organismo. Esta acumulación depende de su forma química siendo las especies orgánicas, como el metilmercurio, las que representan un mayor peligro para la salud, lo que hace necesario disponer de metodologías analíticas sencillas controlar el mercurio en los alimentos.#La presente invención muestra un nuevo material polimérico para la especiación y análisis selectivo de mercurio permitiendo realizar una separación entre el mercurio inorgánico y el metilmercurio en muestras medioambientales y alimentarias.
Patent AU-2000238678-B2 (AU)
Title: Racquet with visually differentiated grommets and method of stringing thereof
Inventor: YIMOYINES DEAN J
IPC: A63B49/00
Filed: 2000-03-06
Granted: 2004-10-21
Abstract: The invention provides an improved racquet and a method of stringing a racquet wherein the racquet includes grommets that are divided into visually differentiated groups in order to make stringing the racquet quicker and easier. According to one embodiment, the grommets are visually differentiated by color, while in another embodiment, the grommets are visually differentiated by shape.
Patent AU-2001235544-B2 (AU)
Title: Auditory signal generator for people suffering from tinnitus
Inventor: NORENA ARNAUD
IPC: H04R25/00
Filed: 2001-01-18
Granted: 2007-12-06
Abstract: The invention concerns an auditory signal generator for reducing, or even eliminating tinnitus. The invention is characterised in that it comprises the following operational phases: a) measuring the absolute auditory thresholds; b) measuring the perceived frequency of tinnitus; c) calculating on the basis of the measurements obtained characteristics of an auditory signal adapted to a subject's particular case, so as to programme said generator enabling it to deliver, with appropriate means, said correcting signal.
Patent AU-2001236073-B2 (AU)
Title: Gene recombinant antibody and its fragment
Inventor: NAKAMURA KAZUYASU
IPC: A61P27/14
Filed: 2001-03-02
Granted: 2006-10-19
Abstract: A recombinant antibody or the antibody fragment thereof which specifically reacts with an extracellular domain of human CCR4; a DNA which encodes the recombinant antibody or the antibody fragment thereof; a method for producing the recombinant antibody or the antibody fragment thereof; a method for immunologically detecting CCR4, a method for immunologically detecting a cell which expressed CCR4 on the cell surface, a method for depleting a cell which expresses CCR4 on the cell surface, and a method for inhibiting production of Th2 cytokine, which comprise using the recombinant antibody according or antibody fragment thereof; a therapeutic or diagnostic agent for Th2-mediated immune diseases; and a therapeutic or diagnostic agent for a blood cancer.
Patent AU-2001256349-B2 (AU)
Title: Construction machine for machining floor surfaces
Inventor: BUSLEY PETER
IPC: E01C23/088
Filed: 2001-05-10
Granted: 2006-06-15
Abstract: The machine to strip the surfaces of roads has a powered roller (8) at the machine frame (4), with exchangeable tools (14) at its mantle surface. A seat (27) for the operator is at the roller working zone, which can be moved into at least one working position along the roller, and parallel to it. The seat is mounted to at least one of the track drives (5) of the machine.
Patent AU-2002211464-B2 (AU)
Title: Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors
Inventor: LU TIANBAO
IPC: A61P29/00
Filed: 2001-10-05
Granted: 2006-06-22
Abstract: Phenyl acetamide compounds are described, including compounds of or a solvate, hydrate or pharmaceutically acceptable salt thereof; wherein R<SUP>3</SUP>-R<SUP>6</SUP>, R<SUP>11</SUP>, B, Y and W are set forth in the specification. The compounds of the invention are potent inhibitors of proteases, especially trypsin-like serine proteases, such as thrombin and factor Xa. Compositions for inhibiting loss of blood platelets, inhibiting formation of blood platelet aggregates, inhibiting formation of fibrin, inhibiting thrombus formation, and inhibiting embolus formation are described. Other uses of compounds of the invention are as anticoagulants either embedded in or physically linked to materials used in the manufacture of devices used in blood collection, blood circulation, and blood storage, such as catheters, blood dialysis machines, blood collection syringes and tubes, blood lines and stents. Additionally, the compounds can be detectably labeled and employed for in vivo imaging of thrombi.
Patent AU-2002300496-B2 (AU)
Title: Biocompatible macroporous polymer scaffold and a process for growing tissue therein
Inventor: HOLY CHANTAL E
IPC: A61K47/34
Filed: 2002-08-09
Granted: 2005-04-21
Abstract: A polymer scaffold is provided having an extensively interconnected macroporous network with macropores having microporous struts as walls. Macropore diameter ranges from about 0.5 to about 3.5 mm. The polymer may be a biocompatible, biodegradable polymer such as poly(lactide-co-glycolide) containing 75% polylactide and 25% polyglycolide. The polymer scaffold is prepared by mixing a liquid polymer with particles, precipitating the liquid polymer with a non-solvent for the liquid polymer and dissolving the particles with a solvent to form the macroporous polymer scaffold which preferably has porosity greater than 50%. The surface of the polymer scaffold may be modified by acid or base treatment, or by collagen or calcium phosphate deposition. The polymer scaffold has utility for tissue engineering, particularly as a scaffold for in vitro and in vivo cell growth.
Patent AU-2002310765-B2 (AU)
Title: Alkylidene pyrazolidinedione derivatives and use for treating diabetes and obesity
Inventor: CHURCH DENNIS
IPC: C07D409/14
Filed: 2002-06-14
Granted: 2007-10-18
Abstract: The present invention is related to the use of alkylidene pyrazolidinedione derivatives of formula (I) for the treatment and/or prevention of diabetes type I and/or II, impaired glucose tolerance, insulin resistance, hyperglycemia, obesity and polycystic ovary syndrome (PCOS). In particular, the present invention is related to the use of alkylidene pyrazolidinedione derivatives of formula (I) to modulate, notably to inhibit the activity of PTPs, in particular PTP1B, TC-PTP, SHP and GLEPP-1. The present invention is furthermore related to novel alkylidene pyrazolidinedione derivatives. (I) R1 and R2 represent independently from each other an unsubstituted or substituted aryl or heteroaryl.
Patent AU-2002322640-B2 (AU)
Title: Continuous optoacoustic monitoring of hemoglobin concentration and hematocrit
Inventor: PROUGH DONALD D
IPC: A61B8/12
Filed: 2002-07-26
Granted: 2008-01-10
Abstract: An optoacoustic apparatus is disclosed which includes a radiation source of pulsed radiation and a probe having a front face to be placed in contact with a tissue site of an animal body. The probe further includes an optical fiber terminating at the surface of the front face of the probe and connected at their other end to a pulsed laser. The front face of the probe also has mounted therein or thereon a piezoelectric transducer for detecting an acoustic response to the radiation pulses connected to a processing unit which converts the transducer signal into a measure of hemoglobin concentration and/or hematocrit of blood.
Patent AU-2002342780-B2 (AU)
Title: Method for producing aqueous styrene-butadiene-IV polymer dispersions
Inventor: MANDERS LAMBERTUS
IPC: C09D109/08
Filed: 2002-09-30
Granted: 2007-11-15
Abstract: A process for preparing an aqueous styrene-butadiene polymer dispersion by free-radical aqueous emulsion polymerization of a monomer mixture M comprising styrene, butadiene, and if desired up to 30% by weight, based on 100% by weight of monomers, of ethylenically unsaturated comonomers other than styrene and butadiene; in a polymerization vessel by a monomer feed technique in the presence of a regulator system containing, based on 100% by weight of monomers, from 0.02 to 0.5% by weight of at least one hydrocarbon HC having from 6 to 20 carbon atoms, selected from compounds which on abstraction of a hydrogen atom form a pentadienyl radical or 1-phenylallyl radical, and alpha-methylstyrene dimer, and from 0.3 to 2% by weight of an organic compound S containing at least one SH group wherein at least 30%, preferably at least 50%, in particular at least 80%, and with particular preference the entirety (or >95%) of hydrocarbon HC is included in the initial charge to the polymerization vessel.
Patent AU-2003204401-B2 (AU)
Title: Hydraulic spring as primary spring for railbound vehicles
Inventor: GEDENK VOLKER
IPC: F16F13/12
Filed: 2003-05-28
Granted: 2009-01-22
Abstract: The hydraulic spring (2) incorporates a gas-filled cavity (18) with a conical shape and a volume which is variable by compression.  An Independent claim is also included for an application of the proposed hydraulic spring as a primary spring for rail vehicles.
Patent AU-2003205461-B2 (AU)
Title: Biphenyl Derivatives and their Use as Antiandrogenic Agents
Inventor: SINGH SHANKAR MOHAN
IPC: A61P5/28
Filed: 2003-02-14
Granted: 2006-08-31
Abstract: Biphenyl derivatives are disclosed for use in the treatment of androgen-dependent diseases, such as prostate cancer, benign prostatic hyperplasia, precocious puberty, polycystic ovarian syndrome, acne, hirsutism, seborrhea, androgenic alopecia and premature male baldness. For example, some preferred compounds having the structure: are formulated together with pharmaceutically acceptable diluent or carrier for topical use in the treatment of acne, hirutism, seborrhea or androgenic alopecia, or for systemic use in the treatment of androgen-dependent prostate cancer.
Patent AU-2003241138-B2 (AU)
Title: Popping oral administration form
Inventor: FIRST SIGAL
IPC: A61K47/04
Filed: 2003-06-18
Granted: 2008-01-24
Abstract: Disclosed are popping pharmaceutical compositions, which comprise OTC or prescription drug, and popping material. The popping material includes pressurized gas trapped within cavities of a pharmaceutically acceptable material in a manner that allows the gas to escape from the pharmaceutical composition upon dissolution, contact with saliva or shattering of the popping material. Such an oral pharmaceutical composition may be popular with children that will prefer it on other ones, which do not pop. Methods for preparation of such oral pharmaceutical compositions are also disclosed.
Patent AU-2003249688-B2 (AU)
Title: Diaphragm water gun
Inventor: ZIMMERMAN JEFFREY C
IPC: B05B7/02
Filed: 2003-06-04
Granted: 2006-02-23
Abstract: A diaphragm actuated toy water gun is provided which includes a housing having a handle with a trigger as well as a barrel with a water ejection nozzle located thereon. A water supply tank is connected to the main housing which can be filled with water. A pump is located on the housing for pumping water from the supply tank to at least one diaphragm chamber located on the housing. The diaphragm chamber is formed between a fixed wall and a flexible diaphragm, which can be deflected and expanded from its neutral position into a diaphragm housing. A release valve C the diaphragm assembly. Actuation of the release valve allows a stream of water to be ejected from the diaphragm water gun.
Patent AU-2003259326-B2 (AU)
Title: Acidic hard surface cleaners
Inventor: NEIMAN DIANE
IPC: C11D3/20
Filed: 2003-08-15
Granted: 2010-04-22
Abstract: The present invention is directed to an acidic hard surface treatment composition which provides a cleaning and disinfecting benefit comprising: an acidic constituent which comprises water soluble organic acid; at least one anionic surfactant constituent; at least one nonionic surfactant constituent; at least one organic solvent constituent; optionally one or more further constituents and the balance, water. The compositions exhibit surprising efficacy against various gram positive and gram negative type pathogenic bacteria, as well as against fungi in the absence of known cationic quaternary ammonium compounds known to be effective against pathogenic bacteria, as well as other known-art antimicrobial constituents and bleach are excluded.
Patent AU-2003278348-B2 (AU)
Title: Method of preparing moulded confectionery articles
Inventor: BROWN ANTHONY JAMES
IPC: A23G1/00
Filed: 2003-10-28
Granted: 2009-08-20
Abstract: The present invention discloses a method of preparing moulded confectionery articles, comprising the steps of: (1) preparing a liquid candy composition which solidifies upon cooling, said liquid candy composition being at a first temperature; (2) preparing a liquid chocolate composition which solidifies upon cooling, said liquid chocolate composition being at a second temperature which is lower than said first temperature; (3) co-depositing the liquid candy composition and the liquid chocolate compositions in the moulds; and (4) cooling the moulded compositions in the moulds so as to solidify the moulded compositions to form moulded confectionery articles; wherein the liquid chocolate composition is subjected to a high shear of at least 100 s<SUP>-1</SUP>, before being co-deposited in the moulds. This treatment enables the candy composition to be deposited into the moulds at a temperature which is higher than has heretofore been considered possible.
Patent AU-2003295466-B2 (AU)
Title: 802.11using a compressed reassociation exchange to facilitate fast handoff
Inventor: REBO RICHARD D
IPC: H04L29/06
Filed: 2003-11-13
Granted: 2009-07-23
Abstract: A method and system for handling roaming mobile nodes in a wireless network. The system uses a Subnet Context Manager to store current Network session keys, security policy and duration of the session (e.g. session timeout) for mobile nodes, which is established when the mobile node is initially authenticated. Pairwise transit keys are derived from the network session key. The Subnet Context Manager handles subsequent reassociation requests. When a mobile node roams to a new access point, the access point obtains the network session key from the Subnet Context Manager and validates the mobile node by computing a new pairwise transient key from the network session key.
Patent AU-2004261182-B2 (AU)
Title: Treatment of dependence withdrawal
Inventor: REIDENBERG BRUCE E
IPC: A61K9/70
Filed: 2004-07-26
Granted: 2008-05-15
Abstract: Dosage regimens of buprenorphine to treat withdrawal or abstinence syndrome in a drug dependent or opioid tolerant patient who is pregnant are described. The method includes treating withdrawal or abstinence syndrome of the patient by transdermal administration of an amount of buprenorphine effective to reduce withdrawal symptoms. For example, a first buprenorphine-containing transdermal dosage form can be administered for a first dosing period that is no more than about 5 days; a second buprenorphine-containing transdermal dosage form for a second dosing period that is no more than about 5 days, the second dosage form comprising the same or a greater dosage of buprenorphine than the first dosage form; and a third buprenorphine-containing transdermal dosage form for a third dosing period that is at least 2 days, the third dosage form comprising the same or a greater dosage of buprenorphine than the second dosage form.
Patent AU-2004281011-B2 (AU)
Title: Method for using three GPS frequencies to resolve carrier-phase integer ambiguities
Inventor: HATCH RONALD R
IPC: G01S19/48
Filed: 2004-10-07
Granted: 2010-03-04
Abstract: A method for generating an ambiguity-resolved, refraction-corrected, and noise-minimized carrier-phase measurement. The method includes forming a first composite measurement using GPS carrier-phase measurements on the L1, L2 and L5 frequencies. To reduce the noise in the first composite measurement, the method further includes forming a second composite measurement using GPS carrier-phase measurements on at least two of the three GPS carrier frequencies. The second composite measurement is formed to have a small multi-path noise therein so that it can be used to smooth the first composite measurement so that the multipath noise is minimized.
Patent AU-2005268627-B2 (AU)
Title: Breathable fabric
Inventor: VAN EMDEN OLIVER
IPC: D03D1/00
Filed: 2005-07-13
Granted: 2011-09-08
Abstract: A fabric comprising a textile layer comprising yarns, wherein said textile layer is permeable to water vapour and impermeable to liquid water; and disposed on at least part of one side of the textile layer is a wicking means.
Patent AU-2005270977-B2 (AU)
Title: Lysis/resealing process and device for incorporating an active ingredient in erythrocytes
Inventor: YANN GODFRIN
IPC: A61K9/50
Filed: 2005-08-04
Granted: 2011-11-24
Abstract: Lysis/resealing process for preparing erythrocytes which contain an active ingredient (e.g. aspariginase or inositol hexaphosphate), the process cornprising the following steps: (1) placing a globular concentrate in suspension in an isotonic solution having a haematocrit level which is equal to or greater than 65 %, with refrigeration at from + 1 to + 8 °C, (2) measuring the osmotic fragility based on a sample of erythrocytes from that same globular concentrate, preferably on a sample of the suspension obtained in step (1), (3) lysis and internalisation procedure of the active ingredient, inside the same chamber, at a temperature which is constantly maintained at from + 1 to + 8 °C, comprising allowing the erythrocyte suspension having a haematocrit level which -is equal to or greater than 65% and a hypotonic lysis solution which is refrigerated at from + 1 to + 8 °C to circulate in a dialysis cartridge ; the lysis parameters being adjusted in accordance with the osmotic fragility previously measured; and (4) resealing procedure carried out in a second chamber at a temperature of from + 30 to + 40 °C by means of a hypertonic solution.